Morgan Stanley Remains a Buy on Welltower (WELL)

Morgan Stanley analyst Vikram Malhorta maintained a Buy rating on Welltower (WELLResearch Report) today and set a price target of $91. The company’s shares closed last Monday at $87.07, close to its 52-week high of $88.87.

According to, Malhorta is a 3-star analyst with an average return of 3.3% and a 61.8% success rate. Malhorta covers the Financial sector, focusing on stocks such as Office Properties Income Trust, National Retail Properties, and Spirit Realty Capital.

Currently, the analyst consensus on Welltower is a Moderate Buy with an average price target of $86.50, implying a -1.6% downside from current levels. In a report issued on August 1, Stifel Nicolaus also maintained a Buy rating on the stock with a $87 price target.

See today’s analyst top recommended stocks >>

Based on Welltower’s latest earnings release for the quarter ending June 30, the company reported a quarterly net profit of $139 million. In comparison, last year the company had a net profit of $155 million.

Based on the recent corporate insider activity of 49 insiders, corporate insider sentiment is negative on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Welltower, Inc. engages in investing with seniors housing operators, post acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience.